European Society of Cardiology reports lower rate of stent thrombosis with second-generation drug-eluting stent.sults of the EXAMINATION trial nt drug coating beats Boston Scientific’s Taxus DES

Lower rate of stent thrombosis found with second-generation drug-eluting stent than with bare metal stent: results of the EXAMINATION trial

Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia

Abbott has announced the initiation of ABSORB BTK, an international clinical trial evaluating the safety and efficacy of the ABSORB™ bioresorbable vascular scaffold (BVS) for the treatment of below-the-knee (BTK) critical limb ischemia.

MitraClip less effective than Mitral Valve Surgery: “Heart Team” approach recommended

The results of the first randomised controlled trial comparing percutaneous mitral valve repair against conventional mitral valve surgery suggests the short term advantages of the technique may be outweighed by inferior long term results compared with conventional surgery.